Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026)

Establishment Labs Holdings (ESTA) recorded quarterly Cash from Financing Activities of -$864000.0 in Q1 2026, down 114.27% quarter-over-quarter from $6.1 million in Q4 2025, and down 325.62% on a YoY basis from $382952.0 in Q1 2025.

Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$864000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 325.62% year-over-year to -$864000.0; the TTM figure through Mar 2026 stood at $39.8 million (down 46.72% YoY), while the FY2025 annual figure was $40.4 million, down 67.88% from the prior year.
  • Cash from Financing Activities was -$864000.0 for Q1 2026 at Establishment Labs Holdings, down from $6.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $84.5 million in Q2 2023 to a low of -$864000.0 in Q1 2026.
  • Historically, Cash from Financing Activities has averaged $20.7 million across 5 years, with a median of $1.7 million in 2022.
  • The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities soared 114501.54% in 2024, then sank 325.62% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $25.0 million in 2022, then slumped by 99.74% to $65000.0 in 2023, then jumped by 114501.54% to $74.5 million in 2024, then slumped by 91.87% to $6.1 million in 2025, then plunged by 114.27% to -$864000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$864000.0 (Q1 2026), $6.1 million (Q4 2025), and $29.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Establishment Labs Holdings 2.54 Bn 2.47 Bn 42.34 Mn -864,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -864,000.00
Mar 31, 2026 -864,000.00
Dec 31, 2025 6.05 Mn
Dec 31, 2025 6.05 Mn
Sep 30, 2025 29.45 Mn
Sep 30, 2025 29.45 Mn
Jun 30, 2025 5.13 Mn
Jun 30, 2025 5.13 Mn
Mar 31, 2025 -203,000.00
Mar 31, 2025 -203,000.00
Dec 31, 2024 74.49 Mn
Dec 31, 2024 74.49 Mn
Sep 30, 2024 -28,000.00
Sep 30, 2024 -28,000.00
Jun 30, 2024 389,000.00
Jun 30, 2024 389,000.00
Mar 31, 2024 51.04 Mn
Mar 31, 2024 51.04 Mn
Dec 31, 2023 65,000.00
Dec 31, 2023 65,000.00